Zobrazeno 1 - 10
of 73
pro vyhledávání: '"M. Rotolo"'
Autor:
P.E. Ocke Reis, L. Roever, I.F. Ocke Reis, F. de Azambuja Fontes, M. Rotolo Nascimento, L. Nunes dos Santos, P. de Almeida Sandri
Publikováno v:
EJVES Short Reports, Vol 33, Iss , Pp 5-8 (2016)
Introduction: Pseudoaneurysms (PSAs) are uncommon, but can occur as a complication of orthopedic procedures, usually associated with femur surgery. This report describes successful management of a PSA of the deep femoral artery (DFA) with an endovasc
Externí odkaz:
https://doaj.org/article/16772761076c4cf883f21009172b9791
Autor:
Regina Royan, Tricia Rae Pendergrast, Marina Del Rios, Shannon M Rotolo, N Seth Trueger, Eve Bloomgarden, Deanna Behrens, Shikha Jain, Vineet M Arora
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 7, p e38324 (2022)
Social media is an important tool for disseminating accurate medical information and combating misinformation (ie, the spreading of false or inaccurate information) and disinformation (ie, spreading misinformation with the intent to deceive). The pro
Externí odkaz:
https://doaj.org/article/a1dcc63addbd48669f0853f28d3587a1
Autor:
Brionna N. Hudson, Hollyann R. Jacobs, Alexander Philbrick, Xiaolong A. Zhou, Michelle M. Simonsen, Julie A. Safirstein, Shannon M. Rotolo
Publikováno v:
Journal of Cystic Fibrosis. 21:1066-1069
Elexacaftor/tezacaftor/ivacaftor (ELX-TEZ-IVA) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator shown to improve lung function and reduce sweat chloride in people with Cystic Fibrosis (CF). The only commonly reported dermatol
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Patients diagnosed with Kawasaki disease (KD) are at a high risk of developing coronary artery aneurysms. Intravenous immune globulin (IVIG) given in combination with aspirin is the standard of treatment for the prevention of coronary aneur
Autor:
Shannon M. Rotolo, Julie Safirstein, David C. Young, Brian Bourque, Stefanie Diloreto, Suyeon Heo, Martine H. Antell
Publikováno v:
Journal of Cystic Fibrosis. 21:339-343
Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA, Trikafta) is the newest Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator drug approved by the Food and Drug Administration. Post-marketing reports with earlier CFTR modulators suggest
Autor:
R. Mugabi, A. Silva, C. Haden, T. Williams, M. Rotolo, J. Brown, R. Jansen, C. Scmidtt, J. Nerem, P. Harms, L. Weinert, G. Li, O. Sahin, C. Rademacher, M. Gottschalk, J. Wells, L. Karriker, A. Tucker, M. Clavijo
Publikováno v:
AASV Annual Meeting.
Publikováno v:
AASV Pre-Conference Seminars.
Autor:
Hanna Phan, Michelle Condren, Mohsain Gill, Rebecca S. Pettit, Wendy Palmrose, Corinne A. Muirhead, Shannon M. Rotolo
Publikováno v:
Pediatric Pulmonology. 56:2879-2887
Introduction To help open the clinician dialogue regarding cannabis use in persons with CF in the U.S., we aimed to describe current practices of use assessment and documentation processes related to cannabis. Methods A cross sectional, anonymous sur
Autor:
Andrew Etteldorf, Ramy Sedhom, Shannon M. Rotolo, Rachel I. Vogel, Christopher M. Booth, Anne H. Blaes, Beth A. Virnig, Stacie B. Dusetzina, Arjun Gupta
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 31(1)
No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling me
Autor:
Shannon M Rotolo, Haley M Fox
Publikováno v:
J Pediatr Pharmacol Ther
Biologic agents, including anti-immunoglobulin E (omalizumab) and anti-interleukin 5 (mepolizumab), target different mediators involved in the inflammatory process and may work synergistically to decrease symptoms in patients with severe asthma. Here